NIRAPARIB SOLID STATE FORM

The present disclosure relates to a stabilized anhydrous p-toluenesulfonic acid salt of niraparib, Form A. The present disclosure is also related to processes for the preparation of the stabilized anhydrous p-toluenesulfonic acid salt of niraparib. Further, the present disclosure also relates to pha...

Full description

Saved in:
Bibliographic Details
Main Author KAVURU, Padmini
Format Patent
LanguageEnglish
French
Published 09.04.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to a stabilized anhydrous p-toluenesulfonic acid salt of niraparib, Form A. The present disclosure is also related to processes for the preparation of the stabilized anhydrous p-toluenesulfonic acid salt of niraparib. Further, the present disclosure also relates to pharmaceutical compositions comprising the stabilized anhydrous p-toluenesulfonic acid salt of niraparib and methods for treating disease using the stabilized anhydrous p-toluenesulfonic acid salt of niraparib. La présente invention concerne un sel d'acide p-toluènesulfonique anhydre stabilisé de niraparib, forme A. Elle concerne également des procédés de préparation du sel d'acide p-toluènesulfonique anhydre stabilisé de niraparib. En outre, la présente invention concerne des compositions pharmaceutiques comprenant le sel d'acide p-toluènesulfonique anhydre stabilisé de niraparib et des procédés de traitement d'une maladie à l'aide du sel d'acide p-toluènesulfonique anhydre stabilisé de niraparib.
Bibliography:Application Number: WO2019US54627